Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-cancer fusion polypeptide

Anti-cancer fusion polypeptide

US Patent 10865250 · Granted Dec 15, 2020

Estimated economic value: $3,281,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion proteins specific for CD137 and GPC32025
Fusion proteins specific for CD137 and GPC32025
Fusion proteins specific for CD137 and GPC32025
Fusion proteins specific for CD137 and GPC32025
Proteins specific for CD1372025
Proteins specific for CD1372025
Proteins specific for CD1372025
Proteins specific for CD1372025
Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC2024
Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC2024
Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC2024
Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC2024